Transforming growth factor-β-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes

European Journal of Immunology

Volumn 29, Issue 1, 1999, Pages 23-29

  Bertone, Stefania ^a,b   Schiavetti, Francesca ^a,b   Bellomo, Rosa ^a   Vitale, Chiara ^a   Ponte, Marco ^a,b   Moretta, Lorenzo ^a,b   Mingari, Maria C ^a,b  

^a CENTRO DI BIOTECNOLOGIE AVANZATE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

HLA class I molecule; Inhibitory receptor; Superantigen; T lymphocyte activation; Transforming growth factor

Indexed keywords

BACTERIAL ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CD94 ANTIGEN; SUPERANTIGEN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TOXIC SHOCK SYNDROME;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD94; BACTERIAL TOXINS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CROSS-LINKING REAGENTS; ENTEROTOXINS; HUMANS; LECTINS, C-TYPE; MEMBRANE GLYCOPROTEINS; MICE; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032921601     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199901)29:01<23::AID-IMMU23>3.0.CO;2-Y     Document Type: Article

References (33)

1. Moretta, A., Bottino, C., Vitale, M., Pende, D., Biassoni, R., Mingari, M. C. and Moretta, L., Receptors for HLA-class I-molecules in human natural killer cells. Annu. Rev. Immunol. 1996. 14: 619-648.
2. Wagtmann, N., Biassoni, R., Cantoni, C., Verdiani, S., Malnati, M., Vitale, M., Bottino, C., Moretta, L., Moretta, A. and Long, E. O., Molecular clones of the p58 natural killer cell receptor reveal Ig-related molecules with diversity in both the extra- and intracellular domains. Immunity 1995. 2: 439-449.
3. Moretta, A., Vitale, M., Bottino, C., Orengo, A. M., Morelli, L., Augugliaro, R., Barbaresi, M., Ciccone, E. and Moretta, L., P58 molecules as putative receptors for MHC class 1 molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J. Exp. Med. 1993. 178: 597-604.
4. Litwin, V., Gumperz, J. E., Parham, P., Phillips, J. H. and Lanier, L. L., NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules. J. Exp. Med. 1994. 180: 537-543.
5. Vitale, M., Sivori, S., Pende, D., Augugliaro, R., Di Donato, C., Amoroso, A., Malnati, M., Bottino, C., Moretta, L. and Moretta, A., Physical and functional independency of p70 and p58 cell receptors for HLA-class I. Their role in the definition of different groups of alloreactive NK cell clones. Proc. Natl. Acad. Sci. USA 1996. 93: 1453-1457.
6. Dohring, C., Scheidegger, D., Samaridis, J., Cella, M. and Colonna, M., A human killer inhibitory receptor specific for HLA-A. J. Immunol. 1996. 156: 3098-3101.
7. Pende, D., Biassoni, R., Cantoni, C., Verdiani, S., Falco, M., Di Donato, C., Accame, L., Bottino, C., Moretta, A. and Moretta, L., The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140 kD disulphide-linked dimer. J. Exp. Med. 1996. 184: 505-518.
8. Cosman, D., Fanger, N., Borges, L., Kubin, M., Chin, W., Peterson, L. and Hsu, M.-L., A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 1997. 7: 273-282.
9. Colonna, M., Navarro, F., Bellón, T., Llano, M., García, P., Samaridis, J., Angman, L., Cella, M. and López-Botet, M., A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 1997. 186: 1809-1818.
10. Cantoni, C., Verdiani, S., Falco, M., Pessino, A., Cilli, M., Conte, R., Pende, D., Ponte, M., Mikaelsson, M. S., Moretta, L. and Biassoni, R., p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily. Eur J. Immunol. 1998. 28: 1980-1990.
11. Aramburu, J., Balboa, M. A., Ramirez, A., Silva, A., Acevedo, A., Sanchez-Madrid, F., de Landazuri, M. O. and López-Botet, M., A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor γ/δ T lymphocytes. Inhibition of IL-2 dependent proliferation by anti-Kp43 monoclonal antibody. J. Immunol. 1990. 44: 3238-3247.
12. Moretta, A., Vitale, M., Sivori, S., Bottino, C., Morelli, L., Augugliaro, R., Barbaresi, M., Pende, D., Ciccone, E., López-Botet, M. and Moretta, L., Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles. J. Exp. Med. 1994. 180:545-555.
13. Chang, C., Rodríguez, A., Carretero, M., López-Botet, M., Phillips, J. H. and Lanier, L. L., Molecular characterization of human CD94: a type II membrane glycoprotein related to the C-type lectin superfamily. Eur. J. Immunol. 1995. 25: 2433-2437.
14. Sivori, S., Vitale, M., Bottino, C., Marcenaro, E., Sanseverino, L., Parolini, S., Moretta, L. and Moretta, L., CD94 functions as a natural killer cell inhibitory receptor for different HLA-CLASS-I alleles. Identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. Eur. J. Immunol. 1996. 26: 2487-2492.
15. Phillips, J. H., Chang, C., Mattson, J., Gumperz, J. E., Parham, P. and Lanier, L. L., CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes. Immunity 1996. 5: 163-172.
16. Carretero, M., Cantoni, C., Bellón, T., Bottino, C., Biassoni, R., Rodriguez, A., Pérez-Villar, J. J., Moretta, L., Moretta, A. and López-Botet, M., The CD94 and NKG2-A C-type lectins covalently assemble to form a NK cell inhibitory receptor for HLA class I molecules. Eur. J. Immunol. 1997. 27: 563-567.
17. Braud, V. M., Allan, D. S. J., O'Callaghan, C. A., Söderström, K., D'Andrea, A., Ogg, G. S., Lazetic, S., Young, N. T., Bell, J. I., Phillips, J. H., Lanier, L. L. and McMichael, A. J., HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998. 391: 795-799.
18. Lee, N., Llano, M., Carretero, M., Ishitani, A., Navarro, F., López-Botet, M. and Geraghty, D. E., HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. USA 1998. 95: 5199-5204.
19. Ferrini, S., Cambiaggi, A., Meazza, R., Sforzini, S., Marciano, S., Mingari, M. C. and Moretta, L., T cell clones expressing the NK-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. Eur. J. Immunol. 1994. 24: 2294-2298.
20. Mingari, M. C., Vitale, C., Cambiaggi, A., Schiavetti, F., Melioli, G., Ferrini, S. and Poggi, A., Cytolytic T-lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA-class I molecules (p58 and CD94) and inhibitory effect on the TCP-mediated target cell lysis or lymphokine production. Int. Immunol. 1995. 7: 697-703.
21. Phillips, J. H., Gumperz, J. E., Parham, P. and Lanier, L. L., Superantigen-dependent cell mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science 1995. 268: 403-405.
22. + T lymphocyte subsets that express HLA-class I specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc. Natl. Acad. Sci. USA 1996. 93: 12433-12438.
23. De Maria, A., Ferraris, A., Guastella, M., Pilia, S., Cantoni, C., Polero, L., Mingari, M. C., Bassetti, D., Fauci, A. S. and Moretta, L., Expression of HLA-class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes. Impairment of specific cytolytic functions. Proc. Natl. Acad Sci. USA 1997. 94: 10285-10288.
24. Ikeda, H., Lethé, B., Lehmann, F., Van Baren, N., Baurain, J.-F., De Smet, C., Chambost, H., Vitale, M., Moretta, A., Boon, T. and Coulie, P. G., Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expression on NK inhibitory receptor. Immunity 1997. 6: 199-208.
25. Mingari, M. C., Moretta, A. and Moretta, L., Regulation of KIR expression in human T lymphocytes. A safety mechanism which may impair protective T cell responses. Immunol. Today 1998. 19: 153-157.
26. Mingari, M. C., Ponte, M., Bertone, S., Schiavetti, F., Vitale, C., Bellomo, R., Moretta, A. and Moretta, L., HLA-class I-specific inhibitory receptors in human T lymphocytes. IL-15-induced expression of CD94/ NKG2A in superantigen-or alloantigen-activated human T cells. Proc. Natl. Acad. Sci. USA 1998. 95: 1172-1177.
27. Letterio, J. J. and Roberts, A. B., Regulation of immune responses by TGF-β. Annu. Rev. Immunol. 1998. 16: 137-161.
28. + cells in response to the toxic shock syndrome toxin-1 (TSST-1) and their deletion upon secondary stimulation. Int. Immunol. 1996. 8: 203-209.
29. Cantoni, C., Biassoni, R., Pende, D., Sivori, S., Accame, L., Pareti, L., Semenzato, G., Moretta, L., Moretta, A. and Bottino, C., The activating form of CD94 receptor complex. The CD94-associated Kp39 protein represents the product of the NKG2-C gene. Eur. J. Immunol. 1998. 28: 327-338.
30. Romagnani, S., Lymphokine production by human T cells in disease state. Annu. Rev. Immunol. 1994. 12: 227-257.
31. Cambiaggi, A., Verthuy, C., Naquet, P., Romagné, F., Ferrier, P., Biassoni, R., Moretta, A., Moretta, L. and Vivier, E., NK-cell acceptance of H-2 mismatch bonemarrow grafts in transgenic mice expressing HLA-Cw3 specific killer-cell inhibitory receptor (CD158b). Proc. Natl. Acad. Sci. USA 1997. 94: 8088-8092.
32. + cells from human thymocyte precursors. J. Exp. Med. 1991. 174: 21-26.
33. Moretta, A., Pantaleo, G., Moretta, L., Mingari, M. C. and Cerottini, J. C., Direct demonstration of the clonogenic potential of every human peripheral blood T cells. Clonal analysis of HLA-DR expression and cytolytic activity. J. Exp. Med. 1983. 157: 743-754.